Category: Jack R – United Therapeutics

I began my second project which is to develop a report on the history of xenotransplantation.

I continued working on my first project which aims to help manufacturers optimize drug development from a market access/government pricing perspective.

I began my first project which aims to help manufacturers optimize drug development from a market access/government pricing perspective.

I went to the final day of the Medicaid and Government Pricing Congress. I attended discussions on industry updates and reasonable assumptions. Speakers also revisited the best price rule and explored its impacts on recent litigation.

I attended day two of the Medicaid and Government Pricing Congress. My schedule included discussions of the Medicaid best price rule and drug pricing reform.

I attended day one of the Medicaid and Government Pricing Congress. I learned the fundamentals of government pricing and reporting.

I will be working with a biotechnology company.